Driehaus Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Driehaus Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,633,541	Closed	-$9.51M	–	434
2022 Q3	$9.51M	Buy	+1,633,541	New	+$10.2M	0.14%	201
2018 Q3	–	Sell	-604,596	Closed	-$3.01M	–	595
2018 Q2	$3.01M	Buy	604,596 +24,350	+4%	+$107K	0.1%	223
2018 Q1	$2.26M	Buy	+580,246	New	+$2.04M	0.08%	244
2014 Q2	–	Sell	-3,830	Closed	-$130K	–	706
2014 Q1	$130K	Buy	+3,830	New	+$131K	﹤0.01%	495

Other funds holding CTIC

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return